HF
ENVB icon

HRT Financial’s Enveric Biosciences ENVB Stock Holding History

HRT Financial’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,385
Closed -$56K – 2865
2025
Q1 		$56K Buy
+3,385
New +$117K ﹤0.01% 2229
2024
Q3 		– Sell
-61
Closed -$6K – 2613
2024
Q2 		$6K Sell
61
-289
-83% -$43.6K ﹤0.01% 2029
2024
Q1 		$63K Buy
+350
New +$67.4K ﹤0.01% 1912
2022
Q3 		– Sell
-2
Closed -$2K – 2991
2022
Q2 		$2K Buy
+2
New +$4.25K ﹤0.01% 2801

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's ENVB Position: Q2 2025 in Review

HRT Financial sold out of Enveric Biosciences (ENVB) in Q2 2025, closing a stake of 3,385 shares — an estimated $56K sold.

HRT Financial first reported a position in ENVB in Q2 2022 and held it in 4 quarters. The position peaked at $63K in Q1 2024. 10 funds tracked by Wall St. Rank hold ENVB as of Q2 2025.

  • HRT Financial reported no remaining Enveric Biosciences position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 3,385 Enveric Biosciences shares in Q2 2025, an estimated $56K.
  • HRT Financial first reported a position in Enveric Biosciences in Q2 2022 and held it in 4 quarters.
  • HRT Financial's Enveric Biosciences position peaked at $63K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.